Trudeau Vincent, Larcher Alessandro, Sun Maxine, Boehm Katharina, Dell'Oglio Paolo, Meskawi Malek, Sosa José, Tian Zhe, Fossati Nicola, Briganti Alberto, Karakiewicz Pierre I
Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada; Department of Urology, University of Montreal Health Center, Montreal, QC, Canada.
Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada; Division of Oncology, Unit of Urology, Istituto di Ricerca, IRCCS Ospedale San Raffaele, Milan, Italy.
Clin Genitourin Cancer. 2016 Apr;14(2):e177-82. doi: 10.1016/j.clgc.2015.10.011. Epub 2015 Oct 29.
Local tumor ablation (LTA) and expectant management (EM) represent competing treatment modalities for patients with small renal masses (SRMs) who are unfit for surgery. We examined the potential social discrepancies in the access of LTA and EM.
A total of 1860 patients with cT1a kidney cancer who had undergone either LTA (n = 553) or EM (n = 1307) from 2000 to 2009 were selected from the Surveillance, Epidemiology, and End Results-Medicare database. The baseline patient data (age, comorbidity status, defined as Charlson comorbidity index [CCI], and several sociodemographic variables) and tumor characteristics were examined. A multivariable analysis predicting access to LTA compared with EM was fitted. The subgroup analyses focused on patients aged ≥ 75 years with a CCI of ≥ 2.
Compared with LTA patients, the EM patients were significantly older (median age, 78 vs. 77 years; P < .001), more frequently unmarried (43% vs. 37%; P = .02), more frequently of African-American ethnicity (14% vs. 8%; P = .005), and more frequently of low socioeconomic status (SES; 55% vs. 46%; P = .001). No differences were seen according to gender, population density, CCI, or tumor size. In a multivariable analysis predicting access to LTA over EM, older age, African-American ethnicity, male gender, low SES, and unmarried status were associated with lower access to LTA (P ≤ .04 for all). In the subgroup of older and sicker patients, none of the previous sociodemographic characteristics represented barriers to LTA access (P ≥ .1 for all).
Sociodemographic characteristics might represent barriers to LTA access for patients with SRMs managed nonoperatively. However, these associations vanished when older and sicker patients were examined.
对于不适合手术的小肾肿块(SRM)患者,局部肿瘤消融(LTA)和观察等待治疗(EM)是两种相互竞争的治疗方式。我们研究了LTA和EM在可及性方面潜在的社会差异。
从监测、流行病学和最终结果 - 医疗保险数据库中选取了2000年至2009年间接受LTA(n = 553)或EM(n = 1307)治疗的1860例cT1a期肾癌患者。检查了患者的基线数据(年龄、合并症状态,定义为Charlson合并症指数[CCI],以及一些社会人口统计学变量)和肿瘤特征。进行了一项多变量分析,以预测与EM相比接受LTA治疗的可及性。亚组分析聚焦于年龄≥75岁且CCI≥2的患者。
与接受LTA治疗的患者相比,接受EM治疗的患者年龄显著更大(中位年龄,78岁对77岁;P <.001),未婚比例更高(43%对37%;P =.02),非裔美国人种族比例更高(14%对8%;P =.005),社会经济地位(SES)较低的比例更高(55%对46%;P =.001)。在性别、人口密度、CCI或肿瘤大小方面未发现差异。在一项预测接受LTA治疗而非EM治疗的多变量分析中,年龄较大、非裔美国人种族、男性性别、SES较低和未婚状态与接受LTA治疗的可及性较低相关(所有P≤.04)。在年龄较大且病情较重的患者亚组中,之前的社会人口统计学特征均未成为接受LTA治疗的障碍(所有P≥.1)。
社会人口统计学特征可能是接受非手术治疗的SRM患者接受LTA治疗的障碍。然而,在检查年龄较大且病情较重的患者时,这些关联消失了。